Stay updated on Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added a 'Last Update Posted' label and removed the 'Last Update Posted (Estimated)' label. This change affects only timestamp display and does not modify study data or page functionality.
    Difference
    0.0%
    Check dated 2026-01-22T05:23:35.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3. This is a small metadata update with no impact on page content or behavior.
    Difference
    0.0%
    Check dated 2026-01-15T02:58:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing participating sites by state (Arizona, California, Connecticut, Florida, Indiana, Massachusetts, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Texas, Washington), replacing the previous per-state location blocks. Updated page revision to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-17T20:19:35.000Z thumbnail image
  5. Check
    58 days ago
    Change Detected
    Summary
    Publications section now states that entries are automatically filled from PubMed and updates the revision label to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-26T13:52:03.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The funding status notice was removed from the page; this does not affect the study details on the ClinicalTrials.gov record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-19T08:34:22.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The new page shows minor formatting updates and a refreshed last update timestamp. Core study content such as design, eligibility criteria, treatment arms, and primary/secondary outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-28T05:16:57.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelumab in Hepatocellular Carcinoma Clinical Trial page.